Masimo (MASI) Non-Current Deferred Tax Liability (2012 - 2026)
Masimo's (MASI) quarterly Non-Current Deferred Tax Liability came in at $400000.0 in Q2 2026, up 100.0% year-on-year from $200000.0 in Q2 2025, and up 100.0% quarter-over-quarter from $200000.0 in Q1 2026.
Masimo (MASI) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends
Masimo's Non-Current Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $400000.0 for Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 100.0% year-over-year to $400000.0 in Q2 2026; TTM through Apr 2026 was $400000.0, a 100.0% increase from a year earlier, with the FY2026 full-year figure at $200000.0, down 99.38% from the prior year.
- Non-Current Deferred Tax Liability grew to $400000.0 in Q2 2026 per MASI's latest filing, from $200000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $232.8 million in Q4 2022 and bottomed at $200000.0 in Q1 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $106.9 million (2024), against an average of $88.9 million.
- Across the five-year window, Non-Current Deferred Tax Liability jumped 4464.71% in 2022 and sank 99.81% in 2025, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $232.8 million in 2022, then retreated by 12.76% to $203.1 million in 2023, then slumped by 84.0% to $32.5 million in 2024, then tumbled by 99.38% to $200000.0 in 2025, then soared by 100.0% to $400000.0 in 2026.
- Per Business Quant, the three latest MASI Non-Current Deferred Tax Liability figures stand at $400000.0 (Q2 2026), $200000.0 (Q1 2026), and $200000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 400,000.00 |
| Apr 4, 2026 | 400,000.00 |
| Jan 3, 2026 | 200,000.00 |
| Jan 3, 2026 | 200,000.00 |
| Jun 28, 2025 | 200,000.00 |
| Jun 28, 2025 | 200,000.00 |
| Mar 29, 2025 | 200,000.00 |
| Mar 29, 2025 | 200,000.00 |
| Dec 28, 2024 | 32.50 Mn |
| Dec 28, 2024 | 32.50 Mn |
| Sep 28, 2024 | 111.30 Mn |
| Sep 28, 2024 | 111.30 Mn |
| Jun 29, 2024 | 102.10 Mn |
| Jun 29, 2024 | 102.10 Mn |
| Mar 30, 2024 | 106.90 Mn |
| Mar 30, 2024 | 106.90 Mn |
| Dec 30, 2023 | 203.10 Mn |
| Dec 30, 2023 | 203.10 Mn |
| Sep 30, 2023 | 112.10 Mn |
| Sep 30, 2023 | 112.10 Mn |